Terminally he describes sleepy exhaustion with incontinence and loss of articulation.
Parkinson then provides six beautifully illustrative case histories of men aged 50, 62, 65, 55, 72 years and a gentleman, the particulars of which could not be obtained ("the lamented subject of which was only seen at a distance'). It is curious that no women were described.
The symptoms-tremor coactus and scelotyrbe festinans, their nature and the opinions of preceding writers are considered in chapter 2 (vide supra). Differential diagnosis is considered in the third chapter. Parkinson Similarly, chapter 5 devoted to means of cure, shows us how frustrating attempts at treatment were at that time. Optimism prevails however, "there appears to be sufficient reason for hoping that some remedial process may ere long be discovered." He discusses in turn: "blood taken from the upper part of the neck, . . . vesicatories applied to the same part and a purulent discharge obtained by use of the Sabine Liniment;". Later he remarks "Until we are better informed regarding the nature of this disease, the employment of internal medicines is scarcely warrantable;".
This classic and exemplary essay ends by generously extolling the virtues of his colleagues professional ardour and devotion and "the benefits bestowed on mankind by the labours of a Morgagni, Hunter, or Baillie."
Later developments
The essay was well received and cited in Cooke's Treatise on Nervous Disease,6 and in Marshall Hall's celebrated Lectures on the Nervous System' and by Robert Bentley Todd (of Todd's palsy) in a paper and in his clinical lectures on paralysis. 8 Marshall Hall had access to necropsy on a 28 year old patient with "hemiParkinsonism" and concluded that the disease was related to a lesion ofthe corpora quadrigemina; he noted a resemblance to tremor mercurialis. By the mid 1850s the disease was well established and described in the works of Stokes and Robert Graves;4 and, it is confounded with a description of action tremor in Romberg's Lehrbuch.9 But little new was added.
Trousseau's 15th Lecture on Clinical Medicine'°was on senile trembling and paralysis agitans. He described rigidity, a sign Parkinson did not pay attention to, and, he explained the scelotyrbe festinans "as his centre ofgravity is thus displaced, he is obliged to run after himself, as it were, so that he keeps trotting and hopping on. " Trousseau-also described the progressive slowing of repeated hand opening, the first clear account of bradykinesia. Although James Parkinson had said "the senses and intellects being uninjured", Trousseau was aware that "the intellect ... gets weakened at last; the patient loses his memory, and his friends notice soon that his mind is not as clear; prococious caducity sets in." Trousseau was a realist: he had, he said, not cured a single patient with medicaments; pneumonia was the common exitus lethalis, but he was not aware of any necropsy performed in France.
Charcot, Vulpian and Ordenstein wrote extensively on the Salpetriere experience which is crystallised" in Lecture 5 of Charcot's Lecons sur les malades du systeme nerveux (1877). Their views leaned heavily on Todd's work. Cold, damp and "emotions morales vives" were held important. Charcot described the affliction as one of the over 50s and classed it as a neurosis that is, with no proper structural cause. Tremor was the cardinal symptom "limited at first to one member, then little by little becoming generalised. " Later "almost pathognomonic, the patient closes the fingers on the thumb as though in the act of spinning wool ... or crumbling bread ..." The movements are slow and seem feeble, although dynamometrical experiments prove that this diminution is not real." He partly ascribed the weakness to "the rigidity which prevails in the muscles."
Charcot recognised "a tendency to propulsion and retropulsion ... the individual is unable to stop-being apparently forced to follow aflying centre ofgravity. " He referred to the "peculiar attitude ofthe body and its members, a fixed look, and immobile features." He analysed the writing, noting the tremulous fine upstrokes when the down-stroke was firm and relatively normal. Speech was "slow, jerky and short ofphrase ... jolted out as it were, like an inexperienced rider on horseback, when the animal is trotting. " Parkinson had not commented on the rigidity of neck, trunk and extremities; Charcot elucidated these signs and said Parkinson had overlooked them. Bradykinesia was not dependent on rigidity "dependent neither on the existence of tremors, nor on that ofmuscular rigidity." He shrewdly anticipated modem concepts of the movement disorder: a lapse of time between the thought and the act. Terminally "the mind becomes clouded and memory is lost. " Tremor faded late in the disease and the final event, as Trousseau had noted, was often pneumonia. His pathological studies added little, but therapeutically he noted the palliative effect of hyoscyamine, the precursor of other belladonna alkaloids.
In Parkinson- ism resulted from a tuberculoma of the contralateral 9 inferior peduncle, destroying the locus niger, he remarked "a lesion ofthe locus niger could very well be the anatomical basis of Parkinson's disease." At that time nothing was known ofthe structure or physiology of the substantia nigra and this was a remarkable and prophetic comment of Brissaud's.
Gowers characteristically surveyed'3 the scene in masterly fashion, reviewing 80 patients of his own. He noted a male preponderance, age of onset 50-60 years in half the cases and a hereditary influence (now disputed) in 15%. Like Charcot he had seldom seen tremor in the face or head. The gait, speech, writing, and the propensity for mental weakness, loss of memory and a tendency to delusions were clearly enunciated. A mixture of "arsenic, Indian hemp (cannabis), sometimes combined with opium" were advocated.
Pathology
Parkinson's disease was considered a syndrome of the motor cortex by Gowers and his predecessors, the function and pathophysiology of the basal ganglia being then obscure. Tretiakoff in 1919 examined the brains of nine Parkinsonian patients and noted'4 a variety of degenerative lesions, but pointed out reduced numbers of pigmented cells in the locus niger which he related to disorder of the muscular tone in Parkinson's disease. He also found peculiar concentric inclusions in the cytoplasm of these nigral cells which had been described by FW Lewy in 1913. A more complete study of the mesencephalon and its neuropathology formed the basis of a classic paper by Foix and Nicolesco'5 in 1925, by which time the essential anatomical substrate, which so frustratingly had eluded James Parkinson, was more or less complete.
The pandemic of encephalitis lethargica of von Economo between 1917 and 1926 left in its wake a new variety of disease: post-encephalitic Parkinsonism. This was the first of the symptomatic causes of the syndrome recognised, but the clinical features and natural history were substantially different from paralysis agitans. Rare sporadic cases are still described, and its historical importance may be as an indicator of the possibility of slow viral infections of the brain, their epidemiology and sequelae. Critchley had attempted to separate "arteriosclerotic Parkinsonism" from paralysis agitans; and a galaxy of striatal Parkinson-like syndromes, bearing a variety of eponyms, have been recognised and demarcated from idiopathic paralysis agitans.
Recent advances
The disease was a commonplace in clinical practice between the Great Wars. My undergraduate textbook (Davidson, 3rd edn, 1956) mentions tinct belladonna, 10 tinct stramonium and hyoscine hydrobromide and "newer synthetic preparations Artane, Lysivane and Pipanol." Great strides have taken place since this time, and since they are well known, I shall mention them only in outline.
Irving Cooper's serendipitous damage to the anterior choroidal artery whilst ligating an aneurysm in a Parkinsonian subject spectacularly controlled contralateral signs; this led to deliberate surgical lesions first in the globus pallidus, then in ventrolateral nucleus of thalamus, effected by the ingenious stereotactic devices of the 1950s with which I failed to cope as a neurosurgical house surgeon. Chemopallidectomy employed alcohol and other destructive agents; later thernal and cryogenic physical methods were used. Unilateral tremor and rigidity were often abolished with striking benefit, but the central features affecting speech, gait, posture and balance were unaffected, and sometimes worsened by these procedures.
The levodopa story, starting in the laboratories of Ehringer and Hornykiewicz in 1960 is too well known to merit repetition here. The late George Cotzias showed that large doses oforal d-l-dopa were clinically highly effective, but I well remember the vomiting, fainting and delay of two to three months before a stable response was obtained. The pure 1-isomer lessened toxicity and the addition of a dopa-decarboxylase inhibitor was an important step forward. Bob Schwab's discovery ofamantadine and the advent of dopamine agonists followed. But the most significant recent advance has been the experimental model afforded by the (I -methyl-4-phenyl-1,2,3,6-tetrahydropyridine) MPTP contaminants. This was discovered in 1976 when a 23 year old American addict took a shortcut to synthesising his own pethidine analogue. One byproduct was MPTP'6 causing severe and pure Parkinsonism on the third day, which responded to levodopa till his suicide 18 months later. The current excitement concerning foetal nigral transplants awaits the validation of time and future research.
David Marsden has in the last 20 years been the preeminent figure in Parkinson's disease research. Preeminent, not only in Great Britain, but throughout Europe and North America. His enormous personal industry, organising capacity and eloquence are now near legendary. Of the recent advances, none has escaped the golden touch of the Marsden research unit at Kings, and more recently at Queen Square. We hope these recent investigative problems and ultimately their solution will be the objects of future histories.
